Smith Hayes Advisers’s AbbVie ABBV Stock Holding History

Smith Hayes Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.4M	Buy	24,511 +410	+2%	+$22.9K	0.28%	96
2015 Q4	$1.43M	Sell	24,101 -19,425	-45%	-$1.12M	0.3%	94
2015 Q3	$2.37M	Buy	43,526 +555	+1%	+$36.1K	0.51%	60
2015 Q2	$2.89M	Buy	42,971 +1,162	+3%	+$75.9K	0.57%	56
2015 Q1	$2.45M	Sell	41,809 -1,417	-3%	-$85.6K	0.49%	63
2014 Q4	$2.83M	Buy	43,226 +1,961	+5%	+$124K	0.59%	49
2014 Q3	$2.38M	Sell	41,265 -1,378	-3%	-$76.5K	0.56%	56
2014 Q2	$2.41M	Buy	42,643 +1,174	+3%	+$61.6K	0.56%	55
2014 Q1	$2.13M	Buy	41,469 +653	+2%	+$33K	0.53%	58
2013 Q4	$2.15M	Buy	40,816 +256	+0.6%	+$12.6K	0.71%	40
2013 Q3	$1.81M	Sell	40,560 -910	-2%	-$40.3K	0.69%	45
2013 Q2	$1.71M	Buy	+41,470	New	+$1.81M	0.71%	45

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Smith Hayes Advisers's ABBV Position: Q1 2016 in Review

Smith Hayes Advisers increased its AbbVie (ABBV) stake by 1.7% in Q1 2016, buying an estimated $22.9K and bringing the position to 24,511 shares worth $1.4M. The position accounts for 0.28% of the portfolio, ranked #96.

Smith Hayes Advisers first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.89M in Q2 2015. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

Smith Hayes Advisers held 24,511 shares of AbbVie worth $1.4M as of Q1 2016.
Smith Hayes Advisers bought 410 AbbVie shares in Q1 2016, an estimated $22.9K.
AbbVie made up 0.28% of Smith Hayes Advisers's portfolio in Q1 2016, its #96 holding.
Smith Hayes Advisers first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
Smith Hayes Advisers's AbbVie position peaked at $2.89M in Q2 2015.
1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.